Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and ...

Day One Biopharmaceuticals, Inc. to Acquire Mersana Therapeutics, Inc.Agreement provides for upfront consideration of $25.00 per share in cash, ...

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...

A peanut patch treatment (Viaskin Peanut Patch; [VP250]) continues to help toddlers safely build tolerance to peanuts over 3 years.

We can use AI to classify cell types, decode their language, and understand how they interact with one another—are the cells ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...

MindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (Nasdaq: HYFT), a Bio-Native AI company, today announced that ...

Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...

Acquisition expands Day One’s portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le)Emi-Le has ...

MindWalk Holdings ( ($HYFT) ) has shared an update. MindWalk Holdings Corp. announced that its Chief Technology Officer, Dr. Dirk Van Hyfte, will ...